Review the successes of 2017 and look to the future of AMR

Superbugs & Superdrugs Conference

Superbugs & Superdrugs Conference

SMi’s Superbugs & Superdrugs Conference

LONODON, UNITED KINGDOM, January 15, 2018 / — London, 19 – 20 March 2018 – SMi’s Superbugs & Superdrugs Conference 2018 will gather a high level of international experts and project decision makers to review the successes of 2017 and look to the future of AMR. Two full days of information, education and networking not to be missed.

All participants will gain the knowledge and get informed on the latest development within scientific communities and on strategies pharmaceutical companies using to develop novel therapeutics
There will also be a large focus on novel candidates and alternatives to antimicrobials; Greater coverage of the regulations, further funding possibilities and partnerships and strategies

The workshop on March, 21st will focus on the transition from in vitro activity to in vivo efficacy, the choice of the right animal model for proof of concept studies, provide examples of relevant animal models with supportive data and interpretation of results as they relate to the clinical condition.

You will: gain an understanding of what animal models can and cannot provide; learn how animal model endpoints relate to clinical endpoints; access in depth discussion of how models are performed; get insights on regulations and constraints in the performance of these models

Further details including a full speaker line-up and detailed programme are available at

Lyudmyla Durneva
SMi Group
+44 (0) 207 827 6088
email us here

Source: EIN Presswire